1991
DOI: 10.1002/1097-0142(19910701)68:1<72::aid-cncr2820680114>3.0.co;2-#
|View full text |Cite
|
Sign up to set email alerts
|

Ifosfamide extrapyramidal neurotoxicity

Abstract: Ifosfamide-associated central nervous system toxicity has been reported in 5% to 30% of patients treated with ifosfamide. Its pattern is characterized by metabolic encephalopathy with confusion, blurred vision, mutism, auditory or visual paranoid hallucinations, seizures, and rarely coma. The biochemical cause of the neurotoxicity is not understood completely, but it is thought to result from an accumulation of drug metabolites with direct central nervous system effects. A case of ifosfamide neurotoxicity is r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
11
0

Year Published

1992
1992
2015
2015

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(13 citation statements)
references
References 15 publications
1
11
0
Order By: Relevance
“…Prompt cessation of ifosfamide at the earliest signs of encephalopathy is essential. 19,20 Methylene blue, thiamine, and intra venous albumin (for those with low serum albumin levels) have been shown to improve recovery in patients with grade 3 or 4 ifosfamide-induced encephalopathy. 18 Modifications to manage acute reversible effects For testicular cancer patients undergoing chemotherapy with curative intent, dose reduction or substitution of cisplatin with carboplatin should be avoided as decreased dose intensity of cisplatin compromises cure rates.…”
Section: Reviewsmentioning
confidence: 99%
“…Prompt cessation of ifosfamide at the earliest signs of encephalopathy is essential. 19,20 Methylene blue, thiamine, and intra venous albumin (for those with low serum albumin levels) have been shown to improve recovery in patients with grade 3 or 4 ifosfamide-induced encephalopathy. 18 Modifications to manage acute reversible effects For testicular cancer patients undergoing chemotherapy with curative intent, dose reduction or substitution of cisplatin with carboplatin should be avoided as decreased dose intensity of cisplatin compromises cure rates.…”
Section: Reviewsmentioning
confidence: 99%
“…The study was therefore terminated prematurely. Other reports have also highlighted this type of toxicity; somnolence is most common, although features such as forgetfulness, nightmares, seizures, tonic clonic spasms, asterixis and extrapyramidal symptoms may occur [11][12][13][14][15]. With severe and progressive encephalopathy, logorrhoea, palilalia, perseveration of writing and speech, and marked disorientation appear after 20 to 50 hours, following which patients may enter a trance, and coma soon follows.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, this drug has been used without excessive neurotoxicity in some cases 7. Some other rare manifestations have also been described, such as extrapyramidal syndrome 8.…”
Section: Discussionmentioning
confidence: 99%